Pharmaceutical companies secured a reprieve from new U.S. tariffs after Trump announced reciprocal levies on over 60 countries, according to Bloomberg. While the pharmaceutical industry was not included in the latest round of tariffs, it remains at risk of future levies. A White House fact sheet confirmed that drugs and certain other products were excluded from the new measures. Trump said the U.S. will ramp up domestic production of key goods, including medicines. He warned pharmaceutical companies to return operations to the U.S. or face steep tariffs. For more coverage on tariffs and how they impact your portfolio, visit benzinga.com.
Category
đź—ž
NewsTranscript
00:00It's Benzinga bringing Wall Street to Main Street.
00:02Pharmaceutical companies secured a temporary reprieve from new U.S. tariffs
00:06after President Trump announced reciprocal levies on over 60 countries, according to Bloomberg.
00:11While the pharmaceutical industry was not included in the latest round of tariffs,
00:14it remains at risk of future levies.
00:17The White House fact sheet confirmed that drugs and certain other products
00:21were excluded from the new measures.
00:23Trump said the U.S. will ramp up domestic production of key goods, including medicines.
00:28He warned pharmaceutical companies to return operations to the U.S. or face steep tariffs.
00:34For coverage on tariffs and how they impact your portfolio, please visit Benzinga.com.